Tag Archives: Temodar

Bevacizumab Beneficial in Newly Diagnosed Glioblastoma?

A large study of patients with newly diagnosed glioblastoma multiforme suggests that the addition of bevacizumab (Avastin) and irinotecan (Camptosar) to standard chemoradiation can extend survival (progression and overall survival) by 6 months.  Bevacizumab (Avastin) is an inhibitor of vascular … Continue reading

Posted in Cancer, Glioblastma | Tagged , , , , , , , , , | Comments Off on Bevacizumab Beneficial in Newly Diagnosed Glioblastoma?